Revolution Medicines, Inc. Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Revolution Medicines, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • Revolution Medicines, Inc. Return On Equity for the quarter ending June 30, 2024 was -34.6 %, a 5.21% increase year-over-year.
  • Revolution Medicines, Inc. annual Return On Equity for 2023 was -38.4 %, a 6.75% increase from 2022.
  • Revolution Medicines, Inc. annual Return On Equity for 2022 was -41.2 %, a 45.7% decline from 2021.
  • Revolution Medicines, Inc. annual Return On Equity for 2021 was -28.3 %, a 12.7% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -38.4 +2.78 +6.75% Jan 1, 2023 Dec 31, 2023
2022 -41.2 -12.9 -45.7% Jan 1, 2022 Dec 31, 2022
2021 -28.3 -3.19 -12.7% Jan 1, 2021 Dec 31, 2021
2020 -25.1 -60.5 -171% Jan 1, 2020 Dec 31, 2020
2019 35.5 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.